Concepedia

Janice A. Lansita

JA

6

Publications

298

Citations

6

H-Index

2002

Active since

Affiliations

BioStrategies (United States)(Current)

Scholar Rock (United States)

Janice A. Lansita is an author at BioStrategies (United States) specializing in medicine, pharmacology, and genetics.

Top concepts

Publications per year

2002–2021

6

Publications

6

Cosegregation of chromosomes containing immortal DNA strands in cells that cycle with asymmetric stem cell kinetics.

Joshua R. Merok, Janice A. Lansita, James Tunstead et al. · PubMed · 2002 · 137 citations

, , +17

Nonclinical Development of ANX005: A Humanized Anti-C1q Antibody for Treatment of Autoimmune and Neurodegenerative Diseases

Janice A. Lansita, Kirsten Mease, Haiyan Qiu et al. · International Journal of Toxicology · 2017 · 98 citations · Full text

, , +19

Nonclinical Development of SRK-181: An Anti-Latent TGFβ1 Monoclonal Antibody for the Treatment of Locally Advanced or Metastatic Solid Tumors

Brian T. Welsh, Ryan Faucette, Sanela Bilic et al. · International Journal of Toxicology · 2021 · 24 citations · Full text

Current strategies in the non-clinical safety assessment of biologics: New targets, new molecules, new challenges

Frank R. Brennan, Laura Andrews, Antonio R. Arulanandam et al. · Regulatory Toxicology and Pharmacology · 2018 · 18 citations

, , +13

A 14-day repeat dose oral gavage range-finding study of a first-in-class CDI investigational antibiotic, in rats

Katherine A. S. Sibley, Jayson Chen, Lee Koetzner et al. · Scientific Reports · 2019 · 11 citations · Full text

Rows per page

1–5 of 6